The FDA approved GLP-1s after testing them in large clinical trials (such as STEP and SURMOUNT) at specific doses and intervals
No prior authorization request, step therapy appeal, or forced fail first attempts
10.1016/j.cgh.2025.02.006 55 HosseinkhanN.NajafiL.JahangiriS.EmamiZ.KhamsehM
The star of the show is Supresa, a novel saffron extract from PLT Health Solutions that's been clinically shown to help reduce snacking frequency and support healthy appetite levels
One user referenced using the patch to get their favorite shorts out of retirement, with the caption: Dont waste your $$ on the [shot emoji]. Another creator promoting the patches wrote in overlaid text, See yall in a month with no waist [hourglass emoji]. Most concerningly, one sponsored post seemingly encouraged breastfeeding mothers to use GLP-1 patches as an alternative to injectable GLP-1 agonists, writing, POV: your a breastfeeding mom who wants to be snatched but cant use those sharp things once a week. (Kind Patches website warns consumers to not use GLP-1 patches if they are pregnant or nursing.)
A severe deficiency can slow things down but restoring adequate levels brings you back to baseline, not above it